Click here to view cell apoptosis assay products
×

Human bFGF/FGF2(Basic Fibroblast Growth Factor) ELISA Kit

  • Cat.No.:E-EL-H6042

  • Reactivity: Human

To Purchase E-EL-H6042

Size:
  • 96T
  • 48T
  • 24T
  • 96T*5
  • 96T*10
Price: $609
Qty:

Product Details

Properties

Assay type Sandwich-ELISA
Format 96T/48T
Assay time 3.5h
Detection range 31.25-2000 pg/mL
Sensitivity 18.75 pg/mL
Sample type &Sample volume serum, plasma and other biological fluids; 100μL
Specificity This kit recognizes Human bFGF/FGF2 in samples. No significant cross-reactivity or interference between Human bFGF/FGF2 and analogues was observed.
Reproducibility Both intra-CV and inter-CV are < 10%.
Application This ELISA kit applies to the in vitro quantitative determination of Human bFGF/FGF2 concentrations in serum, plasma and other biological fluids.

Test Principle

This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human bFGF/FGF2. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human bFGF/FGF2 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human bFGF/FGF2, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human bFGF/FGF2. You can calculate the concentration of Human bFGF/FGF2 in the samples by comparing the OD of the samples to the standard curve.

Kit components & Storage

An unopened kit can be stored at 2-8℃ for 1 month. If the kit is not supposed to be used within 1 month, store the components separately according to the following conditions once the kit is received.
ItemSpecificationsStorage
Micro ELISA Plate(Dismountable) 96T: 8 wells ×12 strips
48T: 8 wells ×6 strips
-20℃, 6 months
Reference Standard 96T: 2 vials
48T: 1 vial
Concentrated Biotinylated Detection Ab (100×) 96T: 1 vial, 120 μL
48T: 1 vial, 60 μL
Concentrated HRP Conjugate (100×) 96T: 1 vial, 120 μL
48T: 1 vial, 60 μL
-20℃(Protect from light), 6 months
Reference Standard & Sample Diluent 1 vial, 20 mL 2-8°C, 6 months
Biotinylated Detection Ab Diluent 1 vial, 14 mL
HRP Conjugate Diluent 1 vial, 14 mL
Concentrated Wash Buffer (25×) 1 vial, 30 mL
Substrate Reagent 1 vial, 10 mL 2-8℃(Protect from light)
Stop Solution 1 vial, 10 mL 2-8°C
Plate Sealer 5 pieces
Manual 1 copy
Certificate of Analysis 1 copy

Technical Data

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, mid range and high level Human bFGF/FGF2 were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, mid range and high level Human bFGF/FGF2 were tested on 3 different plates, 20 replicates in each plate.

  Intra-assay Precision Inter-assay Precision
Sample 1 2 3 1 2 3
n 20 20 20 20 20 20
Mean (pg/mL) 83.31 221.04 991.47 81.61 245.82 870.55
Standard deviation 4.48 10.68 48.09 4.63 11.14 36.39
CV (%) 5.38 4.83 4.85 5.67 4.53 4.18

Recovery

The recovery of Human bFGF/FGF2 spiked at three different levels in samples throughout the range of the assay was evaluated in various matrices.

Sample Type Range (%) Average Recovery (%)
Serum(n=8) 95-105 100
EDTA plasma (n=8) 87-99 94
Cell culture media (n=8) 87-103 95

Linearity

Samples were spiked with high concentrations of Human bFGF/FGF2 and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.

Target Information

Database LinksSwissProt:   P09038
SynonymsFGF-2, B-FGF, BFGF, FGFB, HBGF-2, prostatropin, heparin-binding growth factor 2,FGF-β
Research AreaCancer, Cardiovascular, Developmental biology, Neuroscience, Signal transduction, Stem cells

Assay Procedures

elisa assay procedure 1

1. Add 100μL standard or sample to the wells. Incubate for 90 min at 37°C

elisa assay procedure 2

2. Discard the liquid, immediately add 100μL Biotinylated Detection Ab working solution to each well. Incubate for 60 min at 37°C

elisa assay procedure 3

3. Aspirate and wash the plate for 3 times

elisa assay procedure 4

4. Add 100μL HRP conjugate working solution. Incubate for 30 min at 37°C. Aspirate and wash the plate for 5 times

elisa assay procedure 5

5. Add 90μL Substrate Reagent. Incubate for 15 min at 37°C

elisa assay procedure 6

6. Add 50μL Stop Solution

elisa assay procedure 7

7. Read the plate at 450nm immediately. Calculation of the results

Citations

  1. ACS Applied Materials & Interfaces (2022) IF: 10.383
    Artificial Extracellular Matrix Composed of Heparin-Mimicking Polymers for Efficient Anticoagulation and Promotion of Endothelial Cell Proliferation

    DOI: 10.1021/acsami.2c13892

    PMID: 36302722

    Sample: HUVECs
  2. JOURNAL OF NANOBIOTECHNOLOGY (2022) IF: 10.435
    Targeted delivery of fat extract by platelet membrane-cloaked nanocarriers for the treatment of ischemic stroke

    DOI: 10.1186/s12951-022-01461-2

    PMID: 35642036

    Sample: PLGA-FE
  3. CELL PROLIFERATION (2022) IF: 8.7550
    Tetrahedral framework nucleic acids promote diabetic wound healing via the Wnt signalling pathway

    DOI: 10.1111/cpr.13316

    PMID: 35869570

    Sample: HDFs
  4. BIOMEDICINE & PHARMACOTHERAPY (2023) IF: 7.419
    Stiff substrates inhibit collagen accumulation via integrin α2β1, FAK and Src kinases in human atrial fibroblast and myofibroblast cultures derived from patients with aortal stenosis

    DOI: 10.1016/j.biopha.2023.114289

    Sample: cardiac fibroblast
  5. Biomaterials Science (2020) IF: 6.183
    A multifunctional shape-adaptive and biodegradable hydrogel with hemorrhage control and broad-spectrum antimicrobial activity for wound healing

    DOI: 10.1039/D0BM00800A

    Sample: bFGF/OD/EPL-3 hydrogel
  6. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022) IF: 6.208
    Early Osteogenic Marker Expression in hMSCs Cultured onto Acid Etching-Derived Micro- and Nanotopography 3D-Printed Titanium Surfaces

    DOI: 10.3390/ijms23137070

    PMID: 35806083

    Sample: hBM-MSCs
  7. Stem Cell Research & Therapy (2022) IF: 6.832
    Therapeutic effect of adipose stromal vascular fraction spheroids for partial bladder outlet obstruction induced underactive bladder

    DOI: 10.1186/s13287-022-02739-w

    PMID: 35139904

    Sample: Human umbilical endothelial cells (HUVEC)
  8. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018) IF: 5.5
    Dual Delivery of bFGF- and NGF-Binding Coacervate Confers Neuroprotection by Promoting Neuronal Proliferation

    DOI: 10.1159/000490139

    Sample: Serum
  9. Journal of Clinical Medicine (2022) IF: 4.242
    Cryopreservation in a Standard Freezer: −28 °C as Alternative Storage Temperature for Amniotic Membrane Transplantation

    DOI: 10.3390/jcm11041109

    Sample: Human amniotic membrane (hAM)
  10. JOURNAL OF CELLULAR PHYSIOLOGY (2019) IF: 4.522
    Ganoderma lucidum polysaccharide reduces melanogenesis by inhibiting the paracrine effects of keratinocytes and fibroblasts via IL‐6/STAT3/FGF2 pathway

    DOI: 10.1002/jcp.28844

    Sample: HaCaT cells,fibroblasts (FB) cells
  11. MOLECULES (2019) IF: 3.06
    Effect of Diosmin Administration in Patients with Chronic Venous Disorders on Selected Factors Affecting Angiogenesis

    DOI: 10.3390/molecules24183316

    Sample: serum
  12. BIOMEDICINE & PHARMACOTHERAPY (2019) IF: 3.743
    Sapylin (OK-432) alters inflammation and angiogenesis in vivo and vitro

    DOI: 10.1016/j.biopha.2019.108706

    PMID: 30844656

    Sample: Wound drainage fluid
  13. INTERNATIONAL JOURNAL OF PHOTOENERGY (2021) IF: 2.113
    Experimental Study of the Effect of Photobiomodulation Therapy on the Regulation of the Healing Process of Chronic Wounds

    DOI: 10.1155/2021/3947895

    Sample: serum
  14. PSYCHIATRY RESEARCH (2017) IF: 2.528
    Decreased levels of serum fibroblast growth factor-2 in children with autism spectrum disorder

    DOI: 10.1016/j.psychres.2017.07.028

    Sample: Serum
Show AllShorten

Reviews/Q&A

  • Show all
  • Reviews
  • Q&A
... Show All Show Less

People Also Bought

Apply for Free Shipping 24T ELISA Kit
*Product Name:
*Catalog Number:
Size:
*Name:
*Email:
*Phone:
*Message:
*Country:
*When will you use it?

*Captcha: